Infliximab is an anti-tumor necrosis factor alpha agent. which is indicated for the treatment of resistant ankylosing spondylitis (AS). We presented a patient with AS who developed ventricular tachycardia after premature cessation of infliximab. Ventricular tachycardia did not recur after restarting of infliximab treatment. https://parisnaturalfoodes.shop/product-category/black-currant-oil/